Ovarian Cancer Individualized Scoring System Scoring System
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Role of the ATP7A Transporter in Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Clinical Trial of Bevacizumab Injection
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of JPI-547 in Platinum-resistant, Advanced/Relapsed Ovarian Cancer Subjects Previously Treated With a PARP Inhibitor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)
- Status
- COMPLETED
- Phase
- NA
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.
- Status
- UNKNOWN
- Phase
- N/A
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Intraperitoneal Lidocaine in Ovarian Cancer Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit?
- Status
- COMPLETED
- Phase
- N/A
Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1